Inventor
WEI RONNIE
US20 patents
⚠️ This page may combine multiple inventors who share the name “WEI RONNIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANOFI SA
10 patentsUS10882922B2Jan 5, 2021
Trispecific and/or trivalent binding proteins
SANOFI SA20 citations93
US11530268B2Dec 20, 2022
Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of use for treating viral infection
SANOFI SA15 citations84
US11186649B2Nov 30, 2021
Anti-CD38 antibodies and methods of use
SANOFI SA10 citations84
US11192960B2Dec 7, 2021
Trispecific and/or trivalent binding proteins
SANOFI SA6 citations83
US10626169B2Apr 21, 2020
Multispecific binding molecules having specificity to dystroglycan and laminin-2
SANOFI SA8 citations80
US11613576B2Mar 28, 2023
Trispecific binding proteins, methods, and uses thereof
SANOFI SA3 citations71
US12227573B2Feb 18, 2025
Trispecific binding proteins, methods, and uses thereof
SANOFI SA0 citations61
US11993636B2May 28, 2024
Antigenic OspA polypeptides
SANOFI SA0 citations58
US11932704B2Mar 19, 2024
Trispecific and/or trivalent binding proteins
SANOFI SA0 citations51
US11254737B2Feb 22, 2022
Multispecific binding molecules having specificity to dystroglycan and laminin-2
SANOFI SA0 citations48
GENZYME CORP
5 patentsUS12043665B2Jul 23, 2024
Inhibitors of T-cell activation
GENZYME CORP0 citations59
US11028170B2Jun 8, 2021
Inhibitors of T-cell activation
GENZYME CORP0 citations59
US11505611B2Nov 22, 2022
FGFR3 antibodies and methods of use
GENZYME CORP0 citations58
US10730936B2Aug 4, 2020
Engineered anti-TGF-β antibodies and antigen-binding fragments
GENZYME CORP0 citations48
US9783604B2Oct 10, 2017
Engineered anti-TGF-beta antibodies and antigen-binding fragments
GENZYME CORP1 citations48
DRAGONFLY THERAPEUTICS INC
4 patentsUS12275791B2Apr 15, 2025
Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of use
DRAGONFLY THERAPEUTICS INC1 citations62
US12215157B2Feb 4, 2025
Multi-specific binding proteins that bind CD33, NKG2D, and CD16, and methods of use
DRAGONFLY THERAPEUTICS INC1 citations61
US12384851B2Aug 12, 2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of use
DRAGONFLY THERAPEUTICS INC1 citations60
US12378318B2Aug 5, 2025
Proteins binding NKG2D, CD16 and a tumor-associated antigen
DRAGONFLY THERAPEUTICS INC1 citations60